Toggle navigation
Home
Search
Services
Blog
Contact
About
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W.
Covance Laboratories, Inc., Vienna, VA, United States
Search 19 grants from Daniel Dalgard
Search grants from Covance Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Secure and Privacy-preserving Genome-wide and Phenome-wide Association Studies via Intel Software Guard Extensions (SGX)
HMMER and Infernal: Finding distant homologs of sequences and RNA structures
LEF/TCF Function in Adult Stem Cell Fate and Tumorigenesis
RE188 Labeled Moabs - A Comparision of Labeling Methods
High Resolution of Gene Mapping by IN Situ Hybridization
Recently added grants:
Measuring tumor acidosis with PET/MRI contrast agents
Elucidating the Mechanism of B-Raf Dimerization Inhibition Using (+)-Griffipavixanthone Derivatives
IDH1 is a novel therapeutic target in pancreatic cancer
Brain Pathophysiology of Osteoarthritis Pain
Validation of Critical 1q21 Vulnerabilities in Multiple Myeloma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM025601-009
Application #
3609868
Study Section
Project Start
1981-11-01
Project End
1984-10-31
Budget Start
1985-02-20
Budget End
1984-10-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Covance Laboratories, Inc.
Department
Type
DUNS #
City
Vienna
State
VA
Country
United States
Zip Code
22182
Related projects
NIH 1986
N01 CM
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W. / Covance Laboratories, Inc.
NIH 1985
N01 CM
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W. / Covance Laboratories, Inc.
Comments
Be the first to comment on Daniel Dalgard's grant